897
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Genes predisposing to obesity emphasize G-protein coupled receptor associated pathways in healthy Bulgarian individuals

, , , , , , & show all
Pages 690-697 | Received 11 Apr 2020, Accepted 07 Jul 2020, Published online: 02 Aug 2020

References

  • GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Eng J Med. 2017;377(1):13–27.
  • WHO. Obesity and overweight. 2018. Available from: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight
  • Spinelli A, Buoncristiano M, Kovacs VA, et al. Prevalence of severe obesity among primary school children in 21 European countries. Obes Facts. 2019;12(2):244–258.
  • Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA. 1986;256(1):51–54.
  • Loos RJ, Bouchard C. Obesity-is it a genetic disorder? J Intern Med. 2003;254(5):401–425.
  • Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. 2005;6(3):221–234.
  • EUROSTAT. Tobacco consumption statistics, Luxembourg. 2014.
  • Yang H, Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. 2015;10(10):1556–1566.
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol). 1995;57(1):289–300.
  • Team RC. R: a language and environment for statistical computing Vienna. 2018. Available from: https://www.R-project.org/
  • Piñero J, Bravo À, Queralt-Rosinach N, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45(D1):D833–D839.
  • Chen J, Bardes EE, Aronow BJ, et al. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;37:W305–W311.
  • Joost P, Methner A. Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol. 2002;3(11):research0063. 1.
  • Luo J, Sun P, Siwko S, et al. The role of GPCRs in bone diseases and dysfunctions. Bone Res. 2019;7(1):19.
  • Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219–246.
  • Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107.
  • Shu CJ, Benoist C, Mathis D. The immune system's involvement in obesity-driven type 2 diabetes. Semin Immunol. 2012;24(6):436–442.
  • Krinninger P, Ensenauer R, Ehlers K, et al. Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity. J Clin Endocrinol Metab. 2014;99(7):2500–2509.
  • Tanti J-F, Ceppo F, Jager J, et al. Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne). 2012;3:181.
  • Cantini G, Mannucci E, Luconi M. Perspectives in GLP-1 research: new targets, new receptors. Trends Endocrinol Metab. 2016;27(6):427–438.
  • Hazell GGJ, Hindmarch CC, Pope GR, et al. G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei-serpentine gateways to neuroendocrine homeostasis. Front Neuroendocrinol. 2012;33(1):45–66.
  • Bjenning C, Al-Shamma H, Thomsen W, et al. G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes. Curr Opin Invest Dr. 2004;5(10):1051–1062.
  • Hauser AS, Chavali S, Masuho I, et al. Pharmacogenomics of GPCR drug targets. Cell. 2018;172(1–2):41–54. e19.
  • N’Diaye N, Tremblay J, Hamet P, et al. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing’s syndrome. J Clin Endocrinol Metab. 1998;83(8):2781–2785.
  • Tseng C-C, Zhang X-Y. Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling. Endocrinology. 2000;141(3):947–952.
  • Bollag RJ, Zhong Q, Phillips P, et al. Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology. 2000;141(3):1228–1235.
  • Yamada Y, Hayami T, Nakamura K, et al. Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA. Genomics. 1995;29(3):773–776.
  • Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Invest. 2007;117(1):24–32.
  • Vogel CI, Scherag A, Brönner G, et al. Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups. BMC Med Genet. 2009;10(1):19.
  • Sauber J, Grothe J, Behm M, et al. Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin. Eur J Endocrinol. 2010;163(2):259–264.
  • Su SB, Gong W, Gao J-L, et al. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med. 1999;189(2):395–402.
  • Zhang X, Tang Q-Z, Wan A-Y, et al. SAA1 gene variants and childhood obesity in China. Lipids Health Dis. 2013;12(1):161.
  • Siddiq A, Gueorguiev M, Samson C, et al. Single nucleotide polymorphisms in the neuropeptide Y2 receptor (NPY2R) gene and association with severe obesity in French white subjects. Diabetologia. 2007;50(3):574–584.
  • Hunt SC, Hasstedt SJ, Xin Y, et al. Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects. Obesity (Silver Spring). 2011;19(11):2241–2247.
  • Kim HJ, Lee SY, Kim CM. Association between gene polymorphisms and obesity and physical fitness in Korean children. Biol Sport. 2018;35(1):21.
  • Yulyaningsih E, Zhang L, Herzog H, et al. NPY receptors as potential targets for anti-obesity drug development. Br J Pharmacol. 2011;163(6):1170–1202.
  • Aradillas-García C, Cruz M, Pérez-Luque E, et al. Obesity is associated with the Arg389Gly ADRB1 but not with the Trp64Arg ADRB3 polymorphism in children from San Luis Potosí and León, México. J Biomed Res. 2017;31(1):40–46.
  • Lima JJ, Feng H, Duckworth L, et al. Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metab Clin Exp. 2007;56(6):757–765.
  • Daghestani M, Daghestani M, Daghistani M, et al. ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1. Lipids Health Dis. 2018;17(1):58.
  • Li H-L, Zhang Y-J, Chen X-P, et al. Association between GNB3 c. 825C > T polymorphism and the risk of overweight and obesity: a meta-analysis. Meta Gene. 2016;9:18–25.
  • Ramadhan RS. Molecular analysis of FSH receptor gene in Iraqi women with PCOS syndrome. Middle East Fertil Soc J. 2018;23(4):404–408.
  • Li T-C, Li C-I, Liao L-N, et al. Associations of EDNRA and EDN1 polymorphisms with carotid intima media thickness through interactions with gender, regular exercise, and obesity in subjects in Taiwan: Taichung Community Health Study (TCHS). Biomedicine (Taipei). 2015;5(2):8.
  • Sujatha T, Jayashankar E, Addepally U, et al. Association of follicle-stimulating hormone receptor gene ser680 asn (rs6166) polymorphism with polycystic ovarian syndrome. Int J Reprod Contracept Obstet Gynecol. 2016;5(9):3126–3132.